Genmab (Otc) (GMAB) has released an update.
Genmab A/S has initiated a share buy-back program, aiming to repurchase up to DKK 3.5 billion worth of shares by December 16, 2024. The company has already conducted several transactions, acquiring a total of 81,186 shares, which has increased its treasury shares to 1.42% of the total share capital. This move reflects Genmab’s ongoing commitment to shareholder value and capital efficiency.
For further insights into GMAB stock, check out TipRanks’ Stock Analysis page.
